Moderna (MRNA) News Today $27.05 +0.49 (+1.84%) Closing price 04:00 PM EasternExtended Trading$27.05 0.00 (0.00%) As of 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why is Moderna Up Today?Moderna, Inc. (NASDAQ: MRNA) shares are trading higher today on the back of fresh regulatory approvals for its mNEXSPIKE COVID-19 vaccine, even as investors weigh ongoing regulatory scrutiny and revenue headwinds. FDA approved mNEXSPIKE (mRNA-1283) for adults 65+ and at-risk individuals aged 12–64, opening a new revenue stream Pre-market and intraday trading showed gains after clearance for seniors and those with underlying conditions Analysis highlights potential upside if vaccination rates climb and combination shots gain traction William Blair reaffirmed its “market perform” rating on MRNA, indicating steady analyst sentiment Broader U.S.–China trade tensions kept overall market action mixed, limiting sector momentum Retail investors remain cautious despite the FDA green light for the new vaccine Moderna faces multiple regulatory challenges and policy scrutiny targeting mRNA platforms Revenue prospects may be constrained by limited eligibility criteria and ongoing operating losses Posted 21m agoAI Generated. May Contain Errors. MRNA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Moderna (MRNA) Faces Multiple Regulatory ChallengesJune 2 at 5:06 PM | msn.comModerna: Vaccine Approval (Finally!) Provides A Reason To Be CheerfulJune 2 at 2:08 PM | seekingalpha.comModerna Stock Is Trading Higher Monday: What's Going On?June 2 at 1:52 PM | benzinga.comTop Stock Movers Now: Ford, Cleveland-Cliffs, Moderna, and MoreJune 2 at 12:15 PM | investopedia.comModerna moves higher on FDA approval of new COVID-19 vaccineJune 2 at 11:38 AM | proactiveinvestors.comModerna's New COVID Vaccine Secures FDA-Clearance For Seniors, At-Risk IndividualsJune 2 at 9:06 AM | benzinga.comModerna Stock Is Rising. A New Covid Vaccine Is Coming for Some People.June 2 at 8:37 AM | barrons.comDouglas Lane & Associates LLC Buys 99,713 Shares of Moderna, Inc. (NASDAQ:MRNA)Douglas Lane & Associates LLC raised its stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 12.9% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 873,517 shares of the company's stock after purchasing an additional 99,713 shares during the quarter. DouglaJune 2 at 8:22 AM | marketbeat.comGreen Alpha Advisors LLC Boosts Stock Position in Moderna, Inc. (NASDAQ:MRNA)Green Alpha Advisors LLC raised its holdings in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 69.7% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 28,674 shares of the company's stock afterJune 2 at 7:46 AM | marketbeat.comModerna Shares Gain On FDA Approval For New COVID-19 Vaccine June 2 at 6:13 AM | rttnews.comModerna’s New COVID Vaccine Gets FDA Green Light; Yet Retail Stays CautiousJune 2 at 6:10 AM | msn.comFDA OKs new Moderna COVID-19 vaccine for 65+, others with conditionsJune 1 at 3:08 PM | msn.comModerna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use itJune 1 at 3:08 PM | cbsnews.comInvestors Buy High Volume of Call Options on Moderna (NASDAQ:MRNA)Moderna, Inc. (NASDAQ:MRNA - Get Free Report) was the recipient of some unusual options trading on Friday. Traders purchased 159,220 call options on the company. This is an increase of approximately 72% compared to the average daily volume of 92,832 call options.May 31 at 3:53 PM | marketbeat.comModerna Wins Narrower US Approval for New Covid VaccineMay 31 at 12:20 PM | msn.comModerna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKEMay 31 at 7:41 AM | markets.businessinsider.comFDA approves Moderna’s next-generation COVID vaccine for adults 65 or olderMay 31 at 7:19 AM | nypost.comModerna, Inc. (NASDAQ:MRNA) Shares Sold by California State Teachers Retirement SystemCalifornia State Teachers Retirement System lessened its stake in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 3.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 500,867 shares of the company's stock afteMay 31 at 5:08 AM | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Invests $18.08 Million in Moderna, Inc. (NASDAQ:MRNA)Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 434,914 shares ofMay 31 at 4:43 AM | marketbeat.comHHS cancels funding for Moderna vaccines to fight pandemic fluMay 31 at 2:18 AM | msn.comUS FDA approves Moderna's next-generation COVID vaccine for adults 65 or olderMay 31 at 2:18 AM | msn.comUS FDA approves Moderna's next-gen COVID vaccine for adults 65 or olderMay 31 at 12:34 AM | reuters.comLansforsakringar Fondforvaltning AB publ Invests $4.49 Million in Moderna, Inc. (NASDAQ:MRNA)Lansforsakringar Fondforvaltning AB publ acquired a new position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 107,880 shares of the company's stock, valued at approximately $4,486,000. SeveralMay 30 at 5:33 AM | marketbeat.comTrump admin revokes contract for Moderna bird flu vaccineMay 30 at 3:37 AM | msn.comUS cancels more than $700 million funding for Moderna bird flu vaccineMay 30 at 3:37 AM | msn.comHHS cancels $766M in funding for Moderna to develop MRNA vaccine against bird fluMay 30 at 3:37 AM | msn.comTrump administration yanks Moderna's bird flu vaccine research funding even as company reports promising test resultsMay 30 at 3:37 AM | msn.comModerna, Inc. (MRNA) Bernstein 41st Annual Strategic Decisions Conference Call TranscriptMay 29, 2025 | seekingalpha.comHHS pulls millions in funding for Moderna to develop bird flu vaccinesMay 29, 2025 | msn.comHHS slams 'under-tested' mRNA technology as Trump cuts Moderna's vaccine fundingMay 29, 2025 | msn.comU.S. Cancels Contract With Moderna to Develop Bird Flu VaccineMay 29, 2025 | nytimes.comHHS cancels $590 million contract with Moderna for bird flu vaccineMay 29, 2025 | msn.comTrump administration cancels $766 million Moderna contract to fight pandemic fluThe Trump administration has canceled $766 million awarded to drugmaker Moderna Inc. to develop a vaccine against potential pandemic influenza viruses, including H5N1 bird fluMay 28, 2025 | marketbeat.comUS cancels more $700 million funding for Moderna bird flu vaccineMay 28, 2025 | reuters.comModerna, Inc.: Moderna to Present at Upcoming Conferences in June 2025May 27, 2025 | finanznachrichten.deModerna, Inc. (NASDAQ:MRNA) Shares Sold by Two Sigma Advisers LPTwo Sigma Advisers LP trimmed its stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 70.9% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 103,700 shares of the company's stock after selling 252,800 shares during the quMay 27, 2025 | marketbeat.comWhat is Zacks Research's Forecast for Moderna Q2 Earnings?Moderna, Inc. (NASDAQ:MRNA - Free Report) - Equities researchers at Zacks Research dropped their Q2 2025 EPS estimates for shares of Moderna in a note issued to investors on Wednesday, May 21st. Zacks Research analyst S. Ganoria now expects that the company will post earnings of ($3.26) per shareMay 27, 2025 | marketbeat.comJim Cramer on Moderna (MRNA): “I’ve Been Against This Stock For So Long”May 26, 2025 | insidermonkey.comWill Moderna's Rally Continue?May 26, 2025 | forbes.comBlue Sky Capital Consultants Group Inc. Invests $606,000 in Moderna, Inc. (NASDAQ:MRNA)Blue Sky Capital Consultants Group Inc. acquired a new position in Moderna, Inc. (NASDAQ:MRNA - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 14,563 shares of the company's stock, valued atMay 26, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Reduces Stock Holdings in Moderna, Inc. (NASDAQ:MRNA)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC cut its holdings in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 7.8% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,585,966 shareMay 26, 2025 | marketbeat.comWoodline Partners LP Grows Position in Moderna, Inc. (NASDAQ:MRNA)Woodline Partners LP raised its holdings in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 8.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 142,523 shares of the company's stock after buMay 26, 2025 | marketbeat.comLazard Asset Management LLC Decreases Holdings in Moderna, Inc. (NASDAQ:MRNA)Lazard Asset Management LLC trimmed its position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 81.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,669 shares of the company'sMay 26, 2025 | marketbeat.comModerna, Inc. (NASDAQ:MRNA) Shares Sold by Nuveen Asset Management LLCNuveen Asset Management LLC decreased its position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 1.5% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 672,179 shares of the company's stock after selling 9,998 shares during the period. Nuveen AMay 25, 2025 | marketbeat.comJPMorgan Chase & Co. Lowers Moderna (NASDAQ:MRNA) Price Target to $26.00JPMorgan Chase & Co. lowered their price target on shares of Moderna from $33.00 to $26.00 and set an "underweight" rating for the company in a research note on Thursday.May 24, 2025 | marketbeat.comTwo Sigma Investments LP Has $27.61 Million Holdings in Moderna, Inc. (NASDAQ:MRNA)Two Sigma Investments LP raised its position in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 5.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 664,040 shares of the company's stockMay 24, 2025 | marketbeat.comModerna, Inc. (MRNA) Submits Updated COVID Vaccine for Regulatory ReviewMay 23, 2025 | insidermonkey.comModerna files application for updated COVID vaccineMay 23, 2025 | reuters.comWhat we know about the safety, efficacy of mRNA vaccines amid recent scrutinyMay 23, 2025 | abcnews.go.comToronto Dominion Bank Has $9.58 Million Holdings in Moderna, Inc. (NASDAQ:MRNA)Toronto Dominion Bank grew its position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 75.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 230,320 shares of the company's stock after purchasing an additional 98,843 shares during tMay 23, 2025 | marketbeat.com Get Moderna News Delivered to You Automatically Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address MRNA Media Mentions By Week MRNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRNA News Sentiment▼0.250.90▲Average Medical News Sentiment MRNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRNA Articles This Week▼4225▲MRNA Articles Average Week Get Moderna News Delivered to You Automatically Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies argenx News Beigene News BioNTech News Teva Pharmaceutical Industries News Summit Therapeutics News Intra-Cellular Therapies News Genmab A/S News Dr. Reddy's Laboratories News Ascendis Pharma A/S News Viatris News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MRNA) was last updated on 6/2/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Gold analyst, Sean Brodrick, gave everyday investors an advance notice of this historic surge. When the bul...Weiss Ratings | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThe Social Security Changes No One’s Talking AboutWhile most Americans worry about their next Social Security check... something far bigger is happening behind ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moderna, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Moderna With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MRNA Stock Free MRNA Stock Alerts